| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $127.4M | — | +226.1% |
| Cost of Revenue | $12.0M | — | +651.9% |
| Gross Profit | $105.1M | — | +180.4% |
| R&D Expense | $7.2M | — | +125.9% |
| SG&A Expense | $21.7M | — | +124.1% |
| Operating Income | $63.7M | — | +216.3% |
| Pre-tax Income | $55.6M | — | +169.5% |
| Income Tax | $17.0M | — | — |
| Net Income | $38.6M | — | +87.0% |
| EPS (Basic) | $0.48 | — | +50.0% |
| EPS (Diluted) | $0.43 | — | +43.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $178.1M | +23.0% | +168.7% |
| Short-term Investments | $0 | -100.0% | -100.0% |
| Accounts Receivable | $154.8M | -9.6% | +183.5% |
| Inventory | $30.7M | +3.4% | +310.4% |
| Current Assets | $383.1M | +4.4% | +164.5% |
| Total Assets | $815.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $42.4M | — | +114.7% |
| Capital Expenditures | $729K | — | +7063.2% |
| Investing Cash Flow | $3.0M | — | +1621.9% |
| Financing Cash Flow | -$12.1M | — | -298.5% |
| Free Cash Flow | $41.7M | — | +111.2% |
| +445.3% |
| Current Liabilities | $128.8M | -26.1% | +274.5% |
| Total Liabilities | $378.6M | -10.0% | +991.2% |
| Stockholders' Equity | $437.0M | +7.8% | +280.4% |